Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Brown RA, Niaura R, Lloyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, Abrams D, Miller IW.

Nicotine Tob Res. 2007 Jul;9(7):721-30.

2.

Smoking cessation interventions for smokers with current or past depression.

van der Meer RM, Willemsen MC, Smit F, Cuijpers P.

Cochrane Database Syst Rev. 2013 Aug 21;(8):CD006102. doi: 10.1002/14651858.CD006102.pub2. Review.

PMID:
23963776
3.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007253. doi: 10.1002/14651858.CD007253.pub3. Review.

PMID:
23450574
4.

Interventions for smoking cessation and reduction in individuals with schizophrenia.

Tsoi DT, Porwal M, Webster AC.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007253. doi: 10.1002/14651858.CD007253.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD007253.

PMID:
20556777
5.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
6.

Bupropion: a review of its use in the management of smoking cessation.

Holm KJ, Spencer CM.

Drugs. 2000 Apr;59(4):1007-24. Review.

PMID:
10804045
7.

Review of bupropion for smoking cessation.

Richmond R, Zwar N.

Drug Alcohol Rev. 2003 Jun;22(2):203-20. Review.

PMID:
12850907
8.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
9.

Interventions for waterpipe smoking cessation.

Maziak W, Jawad M, Jawad S, Ward KD, Eissenberg T, Asfar T.

Cochrane Database Syst Rev. 2015 Jul 31;(7):CD005549. doi: 10.1002/14651858.CD005549.pub3. Review.

10.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2014 Jan 8;(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Review.

PMID:
24402784
11.

Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews.

Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T.

Addiction. 2014 Sep;109(9):1414-25. doi: 10.1111/add.12633. Review.

PMID:
24995905
12.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
13.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
14.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
15.

Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis.

Tsoi DT, Porwal M, Webster AC.

Br J Psychiatry. 2010 May;196(5):346-53. doi: 10.1192/bjp.bp.109.066019. Review.

16.

Past major depression and smoking cessation outcome: a systematic review and meta-analysis update.

Hitsman B, Papandonatos GD, McChargue DE, DeMott A, Herrera MJ, Spring B, Borrelli B, Niaura R.

Addiction. 2013 Feb;108(2):294-306. doi: 10.1111/add.12009. Review.

17.

Smoking cessation for adolescents: a review of pharmacological and psychosocial treatments.

Schepis TS, Rao U.

Curr Drug Abuse Rev. 2008 Jun;1(2):142-55. Review.

18.

Smoking cessation: an integral part of lung cancer treatment.

Cataldo JK, Dubey S, Prochaska JJ.

Oncology. 2010;78(5-6):289-301. doi: 10.1159/000319937. Review.

19.

Sex heterogeneity in pharmacogenetic smoking cessation clinical trials.

Schnoll RA, Patterson F.

Drug Alcohol Depend. 2009 Oct 1;104 Suppl 1:S94-9. doi: 10.1016/j.drugalcdep.2008.11.012. Review.

20.

Grey lungs and blue moods: smoking cessation in the context of lifetime depression history.

Wilhelm K, Arnold K, Niven H, Richmond R.

Aust N Z J Psychiatry. 2004 Nov-Dec;38(11-12):896-905. Review.

PMID:
15555023

Supplemental Content

Support Center